Modeling cancer processes with CRISPR-Cas9

被引：9

作者：

Lu, Xiao-Jie ^{[1
]}

Qi, Xiaolong ^{[2
,3
]}

Zheng, Dong-Hui ^{[4
]}

Ji, Li-Juan ^{[5
]}

机构：

[1] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Gastroenterol, Shanghai 200092, Peoples R China

[2] Zhengzhou Univ, Affiliated Hosp 1, Ctr Canc, Biotherapy Ctr, Zhengzhou 450052, Peoples R China

[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Gastroenterol & Hepatol, Shanghai 200092, Peoples R China

[4] Second Peoples Hosp Huaian, Dept Nephrol, Huaian, Peoples R China

[5] Second Peoples Hosp Huaian, Dept Rehabil, Huaian, Peoples R China

来源：

TRENDS IN BIOTECHNOLOGY | 2015年 / 33卷 / 06期

关键词：

GENOME; GENERATION; NUCLEASES; EVENTS;

D O I：

10.1016/j.tibtech.2015.03.007

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

CRISPR-Cas9 is an RNA-guided site-specific DNA editing tool which, together with its reprogrammed versions such as nickase Cas9 and dead Cas9, enables quick modeling of desired combinations of cancer-associated genomic and/or epigenetic aberrations simultaneously or sequentially, thus facilitating massive functional interrogations and therapy testing.

引用

页码：317 / 319

页数：3

共 50 条

[21] CRISPR-Cas9: from Genome Editing to Cancer Research
Chen, Si
Sun, Heng
Miao, Kai
Deng, Chu-Xia
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (12): : 1427 - 1436
[22] Allergan dives into CRISPR-Cas9
不详
NATURE BIOTECHNOLOGY, 2017, 35 (04) : 296 - 296
[23] CRISPR-Cas9 as a Trojan horse
Monte, Daniel F. M.
MOLECULAR THERAPY, 2023, 31 (10) : 2817 - 2818
[24] CRISPR-Cas9: Advances and Challenges
Charpentier, E.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 766 - 766
[25] CRISPR-Cas9 for muscle dystrophies
Ballouhey, Oceane
Bartoli, Marc
Levy, Nicolas
M S-MEDECINE SCIENCES, 2020, 36 (04): : 358 - 366
[26] CRISPR-Cas9: Power And Challenges
Charpentier, Emmanuelle
FASEB JOURNAL, 2016, 30
[27] CRISPR-Cas9 therapies in experimental mouse models of cancer
Estevao, Diogo
Costa, Natalia Rios
da Costa, Rui Gil
Medeiros, Rui
FUTURE ONCOLOGY, 2018, 14 (20) : 2082 - 2094
[28] CRISPR-cas9 genetic targeting of metastatic pancreatic cancer
Bowland, Kirsten
Lai, Jiaying
Teh, Selina Shiqing K.
Bennett, Alexis
Skaist, Alyza
Zhang, Yan
Thompson, Elizabeth
Hruban, Ralph H.
Roberts, Nicholas J.
Karchin, Rachel
Iacobuzio-Donahue, Christine A.
Eshleman, James R.
CANCER RESEARCH, 2024, 84 (06)
[29] Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Liu, Zaoqu
Shi, Meixin
Ren, Yuqing
Xu, Hui
Weng, Siyuan
Ning, Wenjing
Ge, Xiaoyong
Liu, Long
Guo, Chunguang
Duo, Mengjie
Li, Lifeng
Li, Jing
Han, Xinwei
MOLECULAR CANCER, 2023, 22 (01)
[30] Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Zaoqu Liu
Meixin Shi
Yuqing Ren
Hui Xu
Siyuan Weng
Wenjing Ning
Xiaoyong Ge
Long Liu
Chunguang Guo
Mengjie Duo
Lifeng Li
Jing Li
Xinwei Han
Molecular Cancer, 22

← 1 2 3 4 5 →